PVI
IMDX
Pura Vida Investments’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.86M | Sell |
18,700
-928,434
| -98% | -$142M | 17.2% | 2 |
|
|
2025
Q1 | $2.9M | Buy |
947,134
+292,683
| +45% | +$896K | 21.17% | 2 |
|
|
2024
Q4 | $1.56M | Buy |
654,451
+159,106
| +32% | +$379K | 4.93% | 5 |
|
|
2024
Q3 | $1.41M | Hold |
495,345
| – | – | 0.92% | 11 |
|
|
2024
Q2 | $1.46M | Sell |
495,345
-28,583
| -5% | -$84.3K | 0.92% | 17 |
|
|
2024
Q1 | $1.54M | Sell |
523,928
-63,002
| -11% | -$185K | 0.26% | 21 |
|
|
2023
Q4 | $1.47M | Sell |
586,930
-71,191
| -11% | -$178K | 0.22% | 16 |
|
|
2023
Q3 | $2.05M | Sell |
658,121
-12,966,901
| -95% | -$40.5M | 0.39% | 24 |
|
|
2023
Q2 | $3.13M | Sell |
13,625,022
-541,141
| -4% | -$124K | 0.42% | 18 |
|
|
2023
Q1 | $5.02M | Sell |
14,166,163
-3,890,111
| -22% | -$1.38M | 0.51% | 19 |
|
|
2022
Q4 | $5.79M | Hold |
18,056,274
| – | – | 0.3% | 30 |
|
|
2022
Q3 | $13.2M | Hold |
18,056,274
| – | – | 0.76% | 10 |
|
|
2022
Q2 | $16.2M | Buy |
18,056,274
+5,832,321
| +48% | +$5.25M | 0.94% | 10 |
|
|
2022
Q1 | $18.2M | Hold |
12,223,953
| – | – | 0.59% | 12 |
|
|
2021
Q4 | $26.5M | Hold |
12,223,953
| – | – | 0.96% | 9 |
|
|
2021
Q3 | $43.5M | Hold |
12,223,953
| – | – | 1.32% | 6 |
|
|
2021
Q2 | $70.2M | Hold |
12,223,953
| – | – | 2.18% | 2 |
|
|
2021
Q1 | $63.4M | Buy |
12,223,953
+5,941,130
| +95% | +$30.8M | 1.81% | 3 |
|
|
2020
Q4 | $15M | Buy |
6,282,823
+260,289
| +4% | +$622K | 0.55% | 25 |
|
|
2020
Q3 | $8.37M | Buy |
6,022,534
+38,810
| +0.6% | +$53.9K | 0.43% | 30 |
|
|
2020
Q2 | $11.4M | Buy |
5,983,724
+405,441
| +7% | +$774K | 1.1% | 12 |
|
|
2020
Q1 | $13.7M | Sell |
5,578,283
-118,293
| -2% | -$290K | 1.62% | 8 |
|
|
2019
Q4 | $12.8M | Buy |
+5,696,576
| New | +$12.8M | 1.13% | 12 |
|